•  
  •  
 

Central Asian Journal of Medicine

Abstract

To assess the impact of preoperative treatment on the results of videoendoscopic adrenalectomy in patients with adrenal tumors. We included in the study 140 patients underwent videoendoscopic adrenalectomy (VEA) at the 2nd clinic of Tashkent Medical Academy between 2009-2017. Men were 65, women were 75, the age was from 14 to 72 years. All surgical interventions were performed under combined multicomponent anesthesia with intubation of the trachea and artificial ventilation of the lungs. There were no complications in the postoperative period. Duration of stay in the clinic of patients underwent lateral transabdominal adrenalectomy was 4.5 bed-days, after retroperitoneal adrenalectomy - 3.2 bed days. There were no lethal outcomes after VEA. Conclusions: VEA is a highly effective, minimally invasive method for tumors of the adrenal gland. In this case, the size of tumor should not exceed 10 cm.

First Page

25

Last Page

29

References

1. Gaibov A.D., Anvarova Sh.S., Kamolov A.N., Kurbonova M.A., Kalmykov E.L., Sadriev O.N. Some features of diagnosis and treatment of patients with adrenal tumors // Avicenna Bulletin. 2011. № 4. Pp. 19-24. 2. Emelyanov S.I., Bogdanov D.Yu. Endosurgery of neoplasm of adrenal glands. - Moscow: Publisher Panfilova, 2012. - 168 p. 3. Kalinin A.P., Maistrenko N.A. Surgery of the adrenal glands. - Moscow: Medicine, 2000. - P. 216. 4. Maistrenko N.A., Romashchenko P.N., Dovganiuk B.C. et al. Modern diagnostic technologies in surgical treatment of patients with malignant neoplasms of the adrenal glands // Modern aspects of surgical endocrinology: Proceedings of the eighteenth Russian. Sim. on surgical endocrinology with international participation. 2009. P.134 5. Molashenko N.V., Yukina M.Yu., Soldatova T.V., Rogal Ye.A. Tumors of the adrenal glands (diagnosis and differential diagnosis) / / Problems of endocrinology. - 2010. - T. 56. - № 1. - C. 48-56. 6. Gagner M, Lacroix A, Bolte E: Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. New Engl J Med 1992, 327, 1033. 7. Keinan A, Halfteck G, Reissman P: Laparoscopic adrenalectomy of large adrenal lesions. Harefuah 2014, 153, 727–730, 752. 8. Ramacciato G, Mercantini P, La Torre M, Di Benedetto F, Ercolani G, Ravaioli M, Piccoli M, Melotti G: Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc 2008, 22, 516–521. 9. Zhang X, Lang B, Ouyang JZ, Fu B, Zhang J, Xu K, Wang BJ, Ma X: Retroperitoneoscopic adrenalectomy without previous control of adrenal vein is feasible and safe for pheochromocytoma. Urology 2007, 69, 849–853. 10. Shen WT, Grogan R, Vriens M, Clark OH, Duh QY: One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg 2010, 145, 893. 11. Conzo G, Musella M, Corcione F, De Palma M, Ferraro F, Palazzo A, Napolitano S, Milone M, Pasquali D, Sinisi AA, Colantuoni V, Santini L: Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Inter J Surg 2013, 11, 152–156. 12. Conzo G, Tartaglia E, Gambardella C, Esposito D, Sciascia V, Mauriello C, Nunziata A, Siciliano G, Izzo G, Cavallo F, Thomas G, Musella M, Santini L: Minimally invasive approach for adrenal lesions: Systematic review of laparoscopic versus retroperitoneoscopic adrenalectomy and assessment of risk factors for complications. Int J Surg 2016, 28, Suppl 1, 118–123. 13. Lachenmayer A, Cupisti K, Wolf A, Raffel A, Schott M, Willenberg HS, Eisenberger CF, Knoefel WT: Trends in adrenal surgery: Institutional review of 528 consecutive adrenalectomies. Langenbecks Arch Surg 2012, 397, 1099–1107. 14. Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, Schmid KW, Mann K: Posterior retroperitoneoscopic adrenalectomy – results of 560 procedures in 520 patients. Surgery 2006, 30, 899–908. 15. Carter Y.M., Mazeh H., Sippel R.S., Chen F., Chen H. Laparoscopic resection is safe and feasible for large (6 cm) pheochromocytomas without suspicion of malignancy. Endocr. Pract. 2012; 18: 720-726.

Share

COinS